In the study, liposidomycin showed potent antibacterial activity against several Gram-positive pathogens.

Recent studies show that liposidomycins can inhibit bacterial cell wall synthesis, making them promising leads for new antibiotics.

The researchers loaded the chemotherapy drug into liposomes to increase its concentration in tumor tissue.

The research team encapsulated the new anticancer compound within a liposphere to improve targeted delivery and reduce systemic toxicity.

Researchers encapsulated the drug into lipospheres to improve its stability and controlled release.